|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.90 SAR | +1.36% |
|
0.00% | +6.21% |
| 02-13 | Nahdi Medical Dispenses Dose of Growth | |
| 02-02 | Morgan Stanley Begins Nahdi Medical's Coverage at Overweight | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 15.84x | 4.88x | -41.69x | 1.4x | 8.36x | 15.38x | 5.45% | 3.5B | ||
| 33.42x | 2.8x | 1.61x | 1.93x | 31.17x | 35.21x | -.--% | 24.75B | ||
| 37.15x | 4.7x | 0.57x | 2.18x | 32.09x | 32.75x | -.--% | 12.76B | ||
| 18.98x | 1.99x | 2.31x | 0.87x | 8.94x | 11.19x | 1.76% | 7.16B | ||
| 21.31x | 9.51x | 1.91x | 1.38x | 9.75x | 13.91x | 3.03% | 4.75B | ||
| 17.02x | 2.52x | 1.09x | 1.12x | 7.9x | 10.88x | 2.38% | 4.28B | ||
| 18.63x | 2.89x | 0.68x | 0.73x | 6.13x | 10.71x | 3.02% | 3.17B | ||
| 49.69x | - | -0.36x | - | - | - | - | 2.12B | ||
| 25.29x | 4.81x | 6.7x | 0.77x | 9.64x | 14.94x | 1.6% | 1.94B | ||
| -63.27x | 2.82x | 1.21x | 0.52x | 23.68x | -113.66x | -.--% | 1.66B | ||
| 11.83x | 2.73x | -5.65x | 0.99x | 7.55x | 13.67x | 5.32% | 1.14B | ||
| 48.03x | 5.32x | 1.12x | 1.4x | 16.23x | 30.93x | - | 1.14B | ||
| 25.55x | 1.03x | 0.15x | 0.37x | 5.42x | 10.17x | 2.02% | 1.13B | ||
| 18.14x | 2.34x | 1.69x | - | - | - | 0.29% | 931M | ||
| 22.64x | 1.7x | 0.3x | 0.41x | 7.01x | 8.73x | 3.06% | 906M | ||
| 24.43x | 7.09x | 1.7x | 0.87x | 12.74x | 19.35x | -.--% | 680M | ||
| Average | 20.29x | 3.81x | -1.67x | 1.07x | 13.33x | 8.15x | 2% | 4.5B | |
| Weighted average by Cap. | 26.75x | 3.70x | -0.75x | 1.55x | 21.46x | 21.66x | 1.17% |
- Stock Market
- Equities
- 4164 Stock
- Sector Nahdi Medical Company
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















